Two former employees of a leading international testing laboratory used by major Australian sunscreen brands have blown the ...

Biodesix expands its Bio-Rad partnership to validate ddPCR cancer assays, starting with ESR1 mutation testing in breast ...

Neoadjuvant Enhertu then THP improved pathological complete response rate in patients with high-risk, HER2-positive early ...

The United States Tumor Profiling Market is projected to surge from US$ 3.41 billion in 2024 to US$ 7.44 billion by 2033, ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), and Gencurix, Inc. (KOSDAQ: 229000), announced the signing of a strategic agreement establishing Bio-Rad as the exclusive distributor of Gencurix’ ...

A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...

Biodesix has expanded its collaboration with Bio-Rad for the development and clinical validation of in vitro diagnostic (IVD) ...

Event-free survival (EFS) improved by 60% and overall survival (OS) by 50% with the antibody-drug conjugate (ADC) enfortumab vedotin (Padcev) plus pembrolizumab (Keytruda) versus upfront radical ...

Legendary actor and philanthropist William Shatner has joined forces with IdentifySensors Biologics, a pioneer in digital molecular diagnostics, to announce that the company has raised more than $20 ...

A ustralia's sunscreen scandal is deepening with twenty-one products under scrutiny, all linked to a Perth lab, accused of ...

The trial, also referred to as KEYNOTE-905, met its primary end point of EFS, resulting in a 60% reduction in the risk of tumor recurrence, progression, or death of patients treated with neoadjuvant ...